962 related articles for article (PubMed ID: 16724651)
41. Can immunosuppressive drugs slow the progression of IgA nephropathy?
Goumenos D; Ahuja M; Shortland JR; Brown CB
Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
[TBL] [Abstract][Full Text] [Related]
42. Idiopathic membranous nephropathy in the elderly.
Passerini P; Como G; Viganò E; Melis P; Pozzi C; Altieri P; Ponticelli C
Nephrol Dial Transplant; 1993; 8(12):1321-5. PubMed ID: 8159299
[TBL] [Abstract][Full Text] [Related]
43. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
44. [The late results of treating membranous glomerulonephritis].
Belovezhdov N; Robeva R; Dimitrova V
Vutr Boles; 1990; 29(3):53-60. PubMed ID: 2284800
[TBL] [Abstract][Full Text] [Related]
45. The glomerular tip lesion: a steroid responsive nephrotic syndrome.
Beaman M; Howie AJ; Hardwicke J; Michael J; Adu D
Clin Nephrol; 1987 May; 27(5):217-21. PubMed ID: 3594937
[TBL] [Abstract][Full Text] [Related]
46. [Comparison of two cyclophosphamide treatment regimens in nephrotic patients with chronic glomerulonephritis].
Krasnova TN; Shilov EM; Tareeva IE; Gordovskaia NB; Lavrova ON; Miroshnichenko NG; Troepol'skaia OV; Ivanova LV; Ivanov AA
Ter Arkh; 1998; 70(6):14-7. PubMed ID: 9695216
[TBL] [Abstract][Full Text] [Related]
47. The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study.
Banfi G; Moriggi M; Sabadini E; Fellin G; D'Amico G; Ponticelli C
Clin Nephrol; 1991 Aug; 36(2):53-9. PubMed ID: 1934660
[TBL] [Abstract][Full Text] [Related]
48. Focal segmental glomerulosclerosis is not a sufficient predictor of renal outcome in patients with membranous nephropathy.
Heeringa SF; Branten AJ; Deegens JK; Steenbergen E; Wetzels JF
Nephrol Dial Transplant; 2007 Aug; 22(8):2201-7. PubMed ID: 17442739
[TBL] [Abstract][Full Text] [Related]
49. Early initiation of tacrolimus or cyclophosphamide therapy for idiopathic membranous nephropathy with severe proteinuria.
Li X; Lv R; He Q; Li H; Du X; Lin W; Li Q; He X; Wang S; Chen J
J Nephrol; 2008; 21(4):584-91. PubMed ID: 18651550
[TBL] [Abstract][Full Text] [Related]
50. Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study.
Ghiggeri GM; Catarsi P; Scolari F; Caridi G; Bertelli R; Carrea A; Sanna-Cherchi S; Emma F; Allegri L; Cancarini G; Rizzoni GF; Perfumo F
Clin Ther; 2004 Sep; 26(9):1411-8. PubMed ID: 15531003
[TBL] [Abstract][Full Text] [Related]
51. Idiopathic membranous nephropathy: outline and rationale of a treatment strategy.
du Buf-Vereijken PW; Branten AJ; Wetzels JF
Am J Kidney Dis; 2005 Dec; 46(6):1012-29. PubMed ID: 16310567
[TBL] [Abstract][Full Text] [Related]
52. Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
Papasotiriou M; Kalliakmani P; Huang L; Gerolymos M; Goumenos DS; Johnson TS
Nephron Clin Pract; 2012; 121(1-2):c60-7. PubMed ID: 23107829
[TBL] [Abstract][Full Text] [Related]
53. Cyclosporine treatment in idiopathic membranous nephropathy nephrotic syndrome in adults: a retrospective study spanning 15 years.
Tao JL; Liu LL; Wen YB; Gao RT; Li H; Li MX; Li XM; Li XW
Chin Med J (Engl); 2011 Nov; 124(21):3490-4. PubMed ID: 22340164
[TBL] [Abstract][Full Text] [Related]
54. Long-term outcome of patients with membranous nephropathy after complete remission of proteinuria.
Passerini P; Pasquali S; Cesana B; Zucchelli P; Ponticelli C
Nephrol Dial Transplant; 1989; 4(6):525-9. PubMed ID: 2507973
[TBL] [Abstract][Full Text] [Related]
55. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group.
Ponticelli C; Zucchelli P; Passerini P; Cesana B
N Engl J Med; 1992 Aug; 327(9):599-603. PubMed ID: 1640953
[TBL] [Abstract][Full Text] [Related]
56. [Clinical course in 51 patients with idiopathic membranous glomerulopathy].
Ardiles L; Mezzano S; Arriagada A; Caorsi I
Rev Med Chil; 1989 Mar; 117(3):266-72. PubMed ID: 2488518
[TBL] [Abstract][Full Text] [Related]
57. Spontaneous remission of nephrotic syndrome in membranous nephropathy with chronic renal impairment.
Polanco N; Gutiérrez E; Rivera F; Castellanos I; Baltar J; Lorenzo D; Praga M;
Nephrol Dial Transplant; 2012 Jan; 27(1):231-4. PubMed ID: 21624942
[TBL] [Abstract][Full Text] [Related]
58. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
Chen Y; Schieppati A; Chen X; Cai G; Zamora J; Giuliano GA; Braun N; Perna A
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD004293. PubMed ID: 25318831
[TBL] [Abstract][Full Text] [Related]
59. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
[TBL] [Abstract][Full Text] [Related]
60. [A post-thymomectomy case of myasthenia gravis which developed nephrotic syndrome with membranous nephropathy during azathioprine administration].
Konishi T; Miki S; Yoshida A; Tei M
Rinsho Shinkeigaku; 1996 Jul; 36(7):864-8. PubMed ID: 8952354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]